SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-000255
Filing Date
2024-01-12
Accepted
2024-01-12 10:13:35
Documents
48
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cnbx_i10q-113023.htm   iXBRL 10-Q 396773
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cnbx_ex3101.htm EX-31.1 10395
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cnbx_ex3102.htm EX-31.2 10323
4 CERTIFICATION cnbx_ex3201.htm EX-32.1 4779
5 CERTIFICATION cnbx_ex3202.htm EX-32.2 4715
6 GRAPHIC image_001.jpg GRAPHIC 9672
7 GRAPHIC image_002.jpg GRAPHIC 13436
8 GRAPHIC image_003.jpg GRAPHIC 10498
9 GRAPHIC image_004.jpg GRAPHIC 6252
10 GRAPHIC image_005.jpg GRAPHIC 16664
11 GRAPHIC image_006.jpg GRAPHIC 17510
12 GRAPHIC image_007.jpg GRAPHIC 20161
13 GRAPHIC image_008.jpg GRAPHIC 2987
14 GRAPHIC image_009.jpg GRAPHIC 20091
15 GRAPHIC image_010.jpg GRAPHIC 4344
16 GRAPHIC image_011.jpg GRAPHIC 1257
17 GRAPHIC image_012.jpg GRAPHIC 13440
  Complete submission text file 0001683168-24-000255.txt   2169266

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE cnbx-20231130.xsd EX-101.SCH 15583
19 XBRL CALCULATION FILE cnbx-20231130_cal.xml EX-101.CAL 23206
20 XBRL DEFINITION FILE cnbx-20231130_def.xml EX-101.DEF 38923
21 XBRL LABEL FILE cnbx-20231130_lab.xml EX-101.LAB 127957
22 XBRL PRESENTATION FILE cnbx-20231130_pre.xml EX-101.PRE 98828
42 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_i10q-113023_htm.xml XML 124186
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 24530912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)